Does TREMELIMUMAB Cause Pulmonary toxicity? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Pulmonary toxicity have been filed in association with TREMELIMUMAB (IMJUDO). This represents 0.6% of all adverse event reports for TREMELIMUMAB.
15
Reports of Pulmonary toxicity with TREMELIMUMAB
0.6%
of all TREMELIMUMAB reports
1
Deaths
4
Hospitalizations
How Dangerous Is Pulmonary toxicity From TREMELIMUMAB?
Of the 15 reports, 1 (6.7%) resulted in death, 4 (26.7%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Pulmonary toxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREMELIMUMAB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does TREMELIMUMAB Cause?
Pyrexia (178)
Diarrhoea (136)
Death (116)
Colitis (115)
Pneumonitis (87)
Pneumonia (85)
Sepsis (82)
Vomiting (78)
Febrile neutropenia (72)
Malignant neoplasm progression (68)
What Other Drugs Cause Pulmonary toxicity?
AMIODARONE (886)
METHOTREXATE (811)
HYDROXYCHLOROQUINE (411)
RITUXIMAB (404)
TOCILIZUMAB (395)
LEFLUNOMIDE (364)
ABATACEPT (359)
ADALIMUMAB (326)
PEMBROLIZUMAB (318)
ETANERCEPT (291)
Which TREMELIMUMAB Alternatives Have Lower Pulmonary toxicity Risk?
TREMELIMUMAB vs TREMELIMUMAB\TREMELIMUMAB-ACTL
TREMELIMUMAB vs TRENBOLONE
TREMELIMUMAB vs TREOSULFAN
TREMELIMUMAB vs TREPROSTINIL
TREMELIMUMAB vs TREPROSTINIL DIOLAMINE